Key result
Conjunctival microvascular imaging shows promise as a feasible tool for cardiovascular risk prediction.
Why the study?
Current cardiovascular disease risk prediction tools leave gaps, and the role of ocular microcirculation imaging—particularly the conjunctival microvasculature—remains largely unexplored.
Does ocular microcirculation imaging improve cardiovascular disease risk prediction in individuals at risk of cardiovascular disease?
Does ocular microcirculation imaging improve cardiovascular disease risk prediction in individuals at risk of cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Conjunctival microvasculature imaging represents a promising, non-invasive tool that could enhance current cardiovascular risk prediction models.
Cardiovascular disease remains a leading cause of death worldwide despite the use of available cardiovascular disease risk prediction tools. Identification of high-risk individuals via risk stratification and screening at sub-clinical stages, which may be offered by ocular screening, is important to prevent major adverse cardiac events. Retinal microvasculature has been widely researched for potential application in both diabetes and cardiovascular disease risk prediction. However, the conjunctival microvasculature as a tool for cardiovascular disease risk prediction remains largely unexplored. The purpose of this review is to evaluate the current cardiovascular risk assessment methods, identifying gaps in the literature that imaging of the ocular microcirculation may have the potential to fill. This review also explores the themes of machine learning, risk scores, biomarkers, medical imaging, and clinical risk factors. Cardiovascular risk classification varies based on the population assessed, the risk factors included, and the assessment methods. A more tailored, standardised and feasible approach to cardiovascular risk prediction that utilises technological and medical imaging advances, which may be offered by ocular imaging, is required to support cardiovascular disease prevention strategies and clinical guidelines.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2023) conducted a review in Cardiovascular disease risk prediction. Ocular microcirculation imaging vs. Current cardiovascular risk assessment methods was evaluated. Ocular imaging of the conjunctival microvasculature may offer a tailored, standardized, and feasible approach to cardiovascular risk prediction to support prevention strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: